ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
What is ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (CAS N/A) in cosmetics and what are its global regulatory limits?
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (CAS No. N/A) is a verified cosmetic ingredient primarily functioning as Film Forming, Viscosity Controlling, Emulsion Stabilizer in topical formulations. Regulated under KR MFDS (Unregulated) and EU 1223/2009 CosIng (Unregulated) statutory frameworks, it is typically formulated at 0.1–0.8% within an optimal stability window of pH 5–9.
7-Track Official Regulatory Label Names Matrix
Primary Statutory Gazette Only · Zero Machine Translation| Jurisdiction Track | Official Statutory Label Name | One-Click Copy |
|---|---|---|
| 1. Korea (MFDS Standard Name) | ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (KR MFDS Registered) | |
| 2. Korea Former Nomenclature History | — | — |
| 3. European Union (EU CosIng Glossary) | ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER | |
| 4. United States (US PCPC / MoCRA INCI) | ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER | |
| 5. US FDA OTC Monograph Active Name | — (Cosmetic Inactive / Non-OTC) | — |
| 6. China (NMPA IECIC Standard Name) | 丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物 | |
| 7. Japan (JCIA Standard / MHLW Quasi-Drug) | ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (Standard INCI Reference) |
Layer 1 — Statutory Regulatory Limits Across 6 Regions
| Region | Status | Max Limit | Conditions & Statutory Source |
|---|---|---|---|
| Korea (MFDS) | Unregulated | GMP | Listed in official cosmetic inventory |
| Europe (EU) | Unregulated | GMP | Listed in official cosmetic inventory |
| United States (FDA) | Unregulated | GMP | Listed in official cosmetic inventory |
| China (NMPA) | Unregulated | GMP | IECIC Entry #1423 |
| Japan (MHLW) | Unregulated | GMP | Listed in official cosmetic inventory |
| ASEAN (ACD) | Unregulated | GMP | Listed in official cosmetic inventory |
Layer 2 — Toxicological & Historical Safe Use Concentrations (CIR / SCCS / CN IECIC / IFRA)
“EU SCCS Safe Opinion Limit” is the toxicological safe threshold (MoS≥100), whereas “US CIR Reported Max Use” and “CN IECIC Historical Max Use” represent historical maximum concentrations in commercial products.
| Assessment Basis | Application Scope | Concentration Range | Verdict & Dossier Reference |
|---|---|---|---|
| CN IECIC Historical Max Use | leave_on | ≤ 2.6% | Safe (MoS≥100)NMPA IECIC (2025) Entry 01134 (2025) |
| CN IECIC Historical Max Use | rinse_off | ≤ 2% | Safe (MoS≥100)NMPA IECIC (2025) Entry 01134 (2025) |
Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit
Layer 3 — Formulation Usage Guide (Quartiles n≥5) & Physicochemical Compatibility
| Formulation Group | Min – Q1 – Median – Q3 – Max (%) | Role & Mechanism | Source ID |
|---|---|---|---|
| Group A — Aqueous Toner / Serum / Ampoule | 0.1% · 0.15% · 0.25% · 0.35% · 0.8% | Hydrogel thickener & polymeric co-emulsifier | Lubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment |
| Group B — O/W & W/O Emulsion / Lotion / Cream | 0.1% · 0.15% · 0.2% · 0.3% · 0.8% | Surfactant-free polymeric primary/co-emulsifier | Lubrizol Pemulen TDS & CIR Reported Use |
| Group D — Sunscreen (UV) / Color Cosmetics / Foundation | 0.15% · 0.2% · 0.25% · 7.6% · 20% | Sun care & color cosmetics dispersion / sensory modifier | Global Starter Formulation Library Statistical Distribution (n=10, EVONIK 8 · GRANT 2) |
Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery
Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.
pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior
Outside pH 5–9, risk of hydrolysis, viscosity loss, or ionic dissociation increases.
Thermally stable up to 80°C during standard emulsification.
Cellular & Molecular Target Mechanism Flow
Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)
Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.
Trade names are provided strictly for descriptive identification of polymer/emulsifier grades under Article 90(1)(2) of the Trademark Act. All trademarks belong to their respective owners.
Academic & Toxicological Synthesis
Tier 1 SynthesisSynthesized strictly from peer-reviewed PubMed abstracts and official toxicological dossiers linked to this ingredient.
Linked Peer-Reviewed Literature (NIH PubMed) (3)
Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®) is rare [PMID: 39187930 · 2024]
Acrylate polymers and cross-polymers (ACPs) are frequently used cosmetic ingredients. The British Society for Cutaneous Allergy (BSCA) and the UK Cosmetic, Toiletry and Perfumery Association (CTPA) collaborated to investigate the allergenic potential of three commonly-used ACPs. The objective of this study is to determine the prevalence of allergic contact dermatitis (ACD) to three ACPs: glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate, and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®). The BSCA prospectively audited data collected from 20 centres in the UK and Ireland between 1st September 2021 and 1st September 2022. Patients with suspected ACD to (meth)acrylates, with facial dermatitis, or consecutive patients, were patch tested to glyceryl acrylate/acrylic acid co-polymer 10% aqueous (aq.) sodium polyacrylate 2% aq., and to acrylates/C10-30 alkyl acrylate cross-polymer 2% aq. (Carbopol®). The frequencies of positive, irritant, and doubtful reactions were recorded. In total, 1302 patients were patch tested. To glyceryl acrylate/acrylic acid co-polymer, there was one doubtful reaction in a patient allergic to multiple (meth)acrylates, and one irritant. To sodium polyacrylate, there were four irritant reactions, one doubtful, and one positive reaction; in all cases, relevance was unknown and there was no demonstrable (meth)acrylate allergy. There were no reactions to Carbopol®. Sensitisation to these concentrations of the three tested ACPs is rare. Elicitation of dermatitis in (meth)acrylate-sensitised patients by exposure to these three ACPs appears unlikely.
Texture analysis of cosmetic/pharmaceutical raw materials and formulations [PMID: 24575934 · 2014]
The purpose of this work was to quantify textural properties of cosmetic and pharmaceutical raw materials. Textural parameters such as hardness, consistency, cohesiveness, index of viscosity, stickiness and resilience were evaluated. The measurements were performed using texture analyser - a tensile metre equipped with special probes (in the form of acrylic cylinder and stainless steel sphere), which can penetrate the measured sample of a product recording the force, distance and time. The instrument simulates the action of a human finger touching the surface and probing the properties of an object. The set-up has been previously shown to quantify the rheological/textural properties of cosmetic and pharmaceutical products such as creams, lotion and gels as well as rheological behaviour of human skin. The results include the analysis of water, glycerine and mineral oil as well as aqueous solutions of thickeners such as Acrylates/C10-30 Alkyl Acrylate Crosspolymer (Ultrez-20 obtained from Noveon) and carbomer. Solutions of common surfactants and complex surfactant formulations such as shampoos have also been investigated. The results, in the form plots of force as a function of time or distance, resulting from slow bidirectional probe movement (submergence and desubmergence) in the analysed fluid, were interpreted by considering buoyancy, drag and viscous drag force given by Stokes equation. The data can be used to correlate with tactile evaluations of products by trained panel evaluations.
Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels [PMID: 19398245 · 2009]
Incompatibility of leave-on products with an antimicrobial residual can negate the efficacy benefits of chlorhexidine gluconate (CHG) persistence. Two marketed alcohol products containing Carbomer were tested using a pigskin substrate model against Staphylococcus aureus. The CHG residual achieved a 4.22 log(10) reduction (standard deviation [SD] = 0.32) in this study, which was dramatically reduced to a 0.54 (SD = 0.50) and 0.46 (SD = 0.56) after subsequent treatment with incompatible alcohol gel products. A marketed alcohol product containing a nonionic thickener maintained the efficacy of the CHG chemical reservoir (log(10) reduction = 4.26, SD = 0.00). Similar findings were demonstrated when alcohol solutions containing the individual thickening agents were tested as simple formulations. An in vivo test using human forearms and Serratia marcescens similarly demonstrated that the activity of a CHG reservoir (log(10) reduction = 3.73, SD = 0.86) was not reduced by a nonionic thickened product (log(10) reduction = 3.98, SD = 0.72) but was significantly reduced by treatment with alcohol products containing anionic thickeners carbomer (log(10) reduction = -0.32, SD = 0.34) or acrylates/C10-30 alkyl acrylate crosspolymer (log(10) reduction = -0.20, SD = 0.32). The use of anionic thickeners or emulsifiers in leave-on products, including alcohol hand sanitizers, may inactivate the persistent antibacterial activity of CHG.
Frequently Asked Questions (AEO Position 0)
- Q1. What are the official 7-track regulatory label names for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER?
- Standard label names are US PCPC INCI: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER', EU CosIng: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER', KR MFDS: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (KR MFDS Registered)', CN NMPA IECIC: '丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物', and JP JCIA: 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER'.
- Q2. Is ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER restricted or permitted in EU, US, KR, CN, and JP cosmetics?
- Regulatory status summary across 6 jurisdictions — KR: none, EU: none, US: none, CN: none, JP: none, ASEAN: none.
- Q3. What is the typical formulation concentration and optimal pH window for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER?
- In aqueous_serum systems, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER is typically formulated between 0.1% and 0.8% (median 0.25%), with an optimal stability window of pH 5–9.
- Q4. What are the known formulation incompatibilities and synergy pairings for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER?
- Recommended synergy pairings include TROMETHAMINE, ARGININE, CAPRYLIC/CAPRIC TRIGLYCERIDE. Key incompatibilities to avoid: Viscosity loss at pH < 4.5 or high multivalent electrolyte levels; Incompatible with cationic conditioning agents.